{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:31:36Z","timestamp":1792679496383,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00134-021-06449-4","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:06:07Z","timestamp":1624439167000},"page":"819-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E.","family":"Verweij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-725X","authenticated-orcid":false,"given":"Roger J. M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-1508","authenticated-orcid":false,"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-9740","authenticated-orcid":false,"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-0345","authenticated-orcid":false,"given":"Stijn","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-0778","authenticated-orcid":false,"given":"Jochem B.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-1285","authenticated-orcid":false,"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-8033","authenticated-orcid":false,"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-4119","authenticated-orcid":false,"given":"Cornelius J.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5164-5376","authenticated-orcid":false,"given":"Pieter","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-7495","authenticated-orcid":false,"given":"Philipp","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-1350","authenticated-orcid":false,"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-7270","authenticated-orcid":false,"given":"Dylan","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-7785","authenticated-orcid":false,"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-4339","authenticated-orcid":false,"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-8060","authenticated-orcid":false,"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-8492","authenticated-orcid":false,"given":"Peter-Wei Lun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-5980","authenticated-orcid":false,"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-7529","authenticated-orcid":false,"given":"M. Hong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9513-7127","authenticated-orcid":false,"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3343-9610","authenticated-orcid":false,"given":"Bart J. A.","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-5984","authenticated-orcid":false,"given":"Alejandro","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-7729","authenticated-orcid":false,"given":"Thomas R.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-4420","authenticated-orcid":false,"given":"Jeroen A.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-3897","authenticated-orcid":false,"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-4894","authenticated-orcid":false,"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"6449_CR1","doi-asserted-by":"publisher","first-page":"153305","DOI":"10.1016\/j.prp.2020.153305","volume":"217","author":"K Skok","year":"2021","unstructured":"Skok K, Vander K, Setaffy L, Kessler HH, Aberle S, Bargfrieder U, Trauner M, Lax SF (2021) COVID-19 autopsies: procedure, technical aspects and cause of fatal course. Experiences from a single-center. Pathol Res Pract 217:153305. https:\/\/doi.org\/10.1016\/j.prp.2020.153305","journal-title":"Pathol Res Pract"},{"key":"6449_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-03014-0","author":"K Evert","year":"2021","unstructured":"Evert K, Dienemann T, Brochhausen C, Lunz D, Lubnow M, Ritzka M, Keil F, Trummer M, Scheiter A, Salzberger B, Reischl U, Boor P, Gessner A, Jantsch J, Calvisi DF, Evert M, Schmidt B, Simon M (2021) Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-020-03014-0","journal-title":"Virchows Arch"},{"key":"6449_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"AFAD Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J, Dutch-Belgian Mycosis study group (2018) Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 6:782\u2013792. https:\/\/doi.org\/10.1016\/S2213-2600(18)30274-1","journal-title":"Lancet Respir Med"},{"key":"6449_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garc\u00eda","year":"2021","unstructured":"Salmanton-Garc\u00eda J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, Garcia-Vidal C, Falces-Romero I, Machado M, de la Villa S, Schroeder M, Hoyo I, Hanses F, Ferreira-Paim K, Giacobbe DR, Meis JF, Gangneux JP, Rodr\u00edguez-Guardado A, Antinori S, Sal E, Malaj X, Seidel D, Cornely OA, Koehler P, FungiScope European Confederation of Medical Mycology\/The International Society for Human and Animal Mycology Working Group2 (2021) COVID-19-associated pulmonary aspergillosis, March-August 2020. Emerg Infect Dis 27:1077\u20131086. https:\/\/doi.org\/10.3201\/eid2704.204895","journal-title":"Emerg Infect Dis"},{"key":"6449_CR5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, Depuydt P, Giacobbe DR, Janssen NAF, Kullberg BJ, Lagrou K, Lass-Fl\u00f6rl C, Lewis RE, Liu PW, Lortholary O, Maertens J, Martin-Loeches I, Nguyen MH, Patterson TF, Rogers TR, Schouten JA, Spriet I, Vanderbeke L, Wauters J, van de Veerdonk FL (2020) Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med 46:1524\u20131535. https:\/\/doi.org\/10.1007\/s00134-020-06091-6","journal-title":"Intensive Care Med"},{"key":"6449_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S (2014) PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 14:579. https:\/\/doi.org\/10.1186\/s12913-014-0579-0","journal-title":"BMC Health Serv Res"},{"key":"6449_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/bmj.39504.506319.80","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, Vist GE, Sch\u00fcnemann HJ, GRADE Working Group (2008) Incorporating considerations of resources use into grading recommendations. BMJ 336:1170\u20131173. https:\/\/doi.org\/10.1136\/bmj.39504.506319.80","journal-title":"BMJ"},{"key":"6449_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG (2020) Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 71:1367\u20131376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"6449_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K, Vogelaers D, AspICU Study Investigators (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186:56\u201364. https:\/\/doi.org\/10.1164\/rccm.201111-1978OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6449_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13054-016-1326-1","volume":"20","author":"M Schroeder","year":"2016","unstructured":"Schroeder M, Simon M, Katchanov J, Wijaya C, Rohde H, Christner M, Laqmani A, Wichmann D, Fuhrmann V, Kluge S (2016) Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study. Crit Care 20:139. https:\/\/doi.org\/10.1186\/s13054-016-1326-1","journal-title":"Crit Care"},{"key":"6449_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30847-1","author":"P Koehler","year":"2020","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Fl\u00f6rl C, Oladele RO, Vinh DC, Zhu LP, B\u00f6ll B, Br\u00fcggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA, European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM\/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada (2020) Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1","journal-title":"Lancet Infect Dis"},{"key":"6449_CR12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.21037\/jtd.2020.04.32","volume":"12","author":"MA Pritchett","year":"2020","unstructured":"Pritchett MA, Oberg CL, Belanger A, De Cardenas J, Cheng G, Nacheli GC, Franco-Paredes C, Singh J, Toth J, Zgoda M, Folch E (2020) Society for advanced bronchoscopy consensus statement and guidelines for bronchoscopy and airway management amid the COVID-19 pandemic. J Thorac Dis 12:1781\u20131798. https:\/\/doi.org\/10.21037\/jtd.2020.04.32","journal-title":"J Thorac Dis"},{"key":"6449_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/myc.13183","volume":"64","author":"P Koehler","year":"2021","unstructured":"Koehler P, Cornely OA, Kochanek M (2021) Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study. Mycoses 64:55\u201359. https:\/\/doi.org\/10.1111\/myc.13183","journal-title":"Mycoses"},{"key":"6449_CR14","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.iccn.2020.102993","volume":"63","author":"P Lormans","year":"2021","unstructured":"Lormans P, Blot S, Amerlinck S, Devriendt Y, Dumoulin A (2021) COVID-19 acquisition risk among ICU nursing staff with patient-driven use of aerosol-generating respiratory procedures and optimal use of personal protective equipment. Intensive Crit Care Nurs 63:102993. https:\/\/doi.org\/10.1016\/j.iccn.2020.102993","journal-title":"Intensive Crit Care Nurs"},{"key":"6449_CR15","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delliere S, Fodil S, Bretagne S, Megarbane B (2020) Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Resp Med 8:e48\u2013e49","journal-title":"Lancet Resp Med"},{"key":"6449_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/myc.13096","volume":"63","author":"P Koehler","year":"2020","unstructured":"Koehler P, Cornely OA, B\u00f6ttiger BW, Dusse F, Eichenauer DA, Fuchs F, Hallek M, Jung N, Klein F, Persigehl T, Rybniker J, Kochanek M, B\u00f6ll B, Shimabukuro-Vornhagen A (2020) COVID-19 associated pulmonary aspergillosis. Mycoses 63:528\u2013534. https:\/\/doi.org\/10.1111\/myc.13096","journal-title":"Mycoses"},{"key":"6449_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","volume":"202","author":"ALE van Arkel","year":"2020","unstructured":"van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG (2020) COVID-19-associated pulmonary aspergillosis. Am J Resp Crit Care Med 202:132\u2013135. https:\/\/doi.org\/10.1164\/rccm.202004-1038LE","journal-title":"Am J Resp Crit Care Med"},{"key":"6449_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","volume":"10","author":"L Rutsaert","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, Dits H, Van Regenmortel N (2020) COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care 10:71. https:\/\/doi.org\/10.1186\/s13613-020-00686-4","journal-title":"Ann Intensive Care"},{"key":"6449_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1065","author":"M Bartoletti","year":"2020","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G, Francalanci E, Giuntoli L, Rubin A, Moroni A, Ambretti S, Trapani F, Vatamanu O, Ranieri VM, Castelli A, Baiocchi M, Lewis R, Giannella M, Viale P, PREDICO study group (2020) Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1065","journal-title":"Clin Infect Dis"},{"key":"6449_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1298","author":"PL White","year":"2020","unstructured":"White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, Pandey M, Whitaker H, May A, Morgan M, Wise MP, Healy B, Blyth I, Price JS, Vale L, Posso R, Kronda J, Blackwood A, Rafferty H, Moffitt A, Tsitsopoulou A, Gaur S, Holmes T, Backx M (2020) A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1298","journal-title":"Clin Infect Dis"},{"key":"6449_CR21","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2020.460","author":"C Sarrazyn","year":"2020","unstructured":"Sarrazyn C, Dhaese S, Demey B, Vandecasteele S, Reynders M, Van Praet JT (2020) Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis. Infect Control Hosp Epidemiol. https:\/\/doi.org\/10.1017\/ice.2020.460","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6449_CR22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani JL (2020) Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect 26:1706\u20131708. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.010","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/mmy\/myaa078","volume":"59","author":"D Dupont","year":"2021","unstructured":"Dupont D, Menotti J, Turc J, Miossec C, Wallet F, Richard JC, Argaud L, Paulus S, Wallon M, Ader F, Persat F (2021) Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Med Mycol 59:110\u2013114. https:\/\/doi.org\/10.1093\/mmy\/myaa078","journal-title":"Med Mycol"},{"key":"6449_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/myc.13135","volume":"63","author":"N Nasir","year":"2020","unstructured":"Nasir N, Farooqi J, Mahmood SF, Jabeen K (2020) COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan. Mycoses 63:766\u2013770. https:\/\/doi.org\/10.1111\/myc.13135","journal-title":"Mycoses"},{"key":"6449_CR25","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/myc.13185","volume":"63","author":"H Mitaka","year":"2020","unstructured":"Mitaka H, Perlman DC, Javaid W, Salomon N (2020) Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City. Mycoses 63:1368\u20131372. https:\/\/doi.org\/10.1111\/myc.13185","journal-title":"Mycoses"},{"key":"6449_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin JM, Marcelin AG, Monsel A, Luyt CE, Blaize M (2021) Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med 203:307\u2013317. https:\/\/doi.org\/10.1164\/rccm.202009-3400OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6449_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/myc.13254","volume":"64","author":"EFJ Meijer","year":"2021","unstructured":"Meijer EFJ, Dofferhoff ASM, Hoiting O, Meis JF (2021) COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series. Mycoses 64:457\u2013464. https:\/\/doi.org\/10.1111\/myc.13254","journal-title":"Mycoses"},{"key":"6449_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/myc.13259","volume":"64","author":"R van Grootveld","year":"2021","unstructured":"van Grootveld R, van Paassen J, de Boer MGJ, Claas ECJ, Kuijper EJ, van der Beek MT, LUMC-COVID-19 Research Group (2021) Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate. Mycoses 64:641\u2013650. https:\/\/doi.org\/10.1111\/myc.13259","journal-title":"Mycoses"},{"key":"6449_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab223","author":"N Permpalung","year":"2021","unstructured":"Permpalung N, Chiang TP, Massie AB, Zhang SX, Avery RK, Nematollahi S, Ostrander D, Segev DL, Marr KA (2021) COVID-19 associated pulmonary aspergillosis in mechanically ventilated patients. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciab223","journal-title":"Clin Infect Dis"},{"key":"6449_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","volume":"24","author":"T Mercier","year":"2020","unstructured":"Mercier T, Dunbar A, Veldhuizen V, Holtappels M, Schauwvlieghe A, Maertens J, Rijnders B, Wauters J (2020) Point of care aspergillus testing in intensive care patients. Crit Care 24:642. https:\/\/doi.org\/10.1186\/s13054-020-03367-7","journal-title":"Crit Care"},{"key":"6449_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/myc.13216","volume":"64","author":"CM Roman-Montes","year":"2021","unstructured":"Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomel\u00ed P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF (2021) Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses 64:364\u2013371. https:\/\/doi.org\/10.1111\/myc.13216","journal-title":"Mycoses"},{"key":"6449_CR32","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.18632\/oncotarget.7471","volume":"7","author":"E Azoulay","year":"2016","unstructured":"Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F (2016) (1, 3)-beta-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget 7:21484\u201321495. https:\/\/doi.org\/10.18632\/oncotarget.7471","journal-title":"Oncotarget"},{"key":"6449_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/RTI.0000000000000542","volume":"35","author":"M Lang","year":"2020","unstructured":"Lang M, Som A, Mendoza DP, Flores EJ, Li MD, Shepard JO, Little BP (2020) Detection of Unsuspected Coronavirus Disease 2019 Cases by Computed Tomography and Retrospective Implementation of the Radiological Society of North America\/Society of Thoracic Radiology\/American College of Radiology Consensus Guidelines. J Thorac Imaging 35:346\u2013353. https:\/\/doi.org\/10.1097\/RTI.0000000000000542","journal-title":"J Thorac Imaging"},{"key":"6449_CR34","doi-asserted-by":"publisher","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","volume":"56","author":"D Armstrong-James","year":"2020","unstructured":"Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, Mehra V, Pagliuca T, Patel B, Rhodes J, Schelenz S, Shah A, van de Veerdonk FL, Verweij PE, White PL, Fisher MC (2020) Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J 56:2002554. https:\/\/doi.org\/10.1183\/13993003.02554-2020","journal-title":"Eur Respir J"},{"key":"6449_CR35","doi-asserted-by":"publisher","first-page":"790.e1","DOI":"10.1016\/j.cmi.2020.12.005","volume":"27","author":"S Delli\u00e8re","year":"2020","unstructured":"Delli\u00e8re S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic PA, Salmona M, D\u00e9pret F, Ghelfenstein-Ferreira T, Plaud B, Chousterman B, Bretagne S, Azoulay E, Mebazaa A, Megarbane B, Alanio A (2020) Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect 27:790.e1-790.e5. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.005","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab008","author":"S Boyd","year":"2021","unstructured":"Boyd S, Martin-Loeches I (2021) Rates of Aspergillus co-infection in COVID patients in ICU not as high as previously reported. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciab008","journal-title":"Clin Infect Dis"},{"key":"6449_CR37","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.tmaid.2020.101752","volume":"38","author":"S Antinori","year":"2020","unstructured":"Antinori S, Rech R, Galimberti L, Castelli A, Angeli E, Fossali T, Bernasconi D, Covizzi A, Bonazzetti C, Torre A, Carsana L, Tonello C, Zerbi P, Nebuloni M (2020) Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge. Travel Med Infect Dis 38:101752. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101752","journal-title":"Travel Med Infect Dis"},{"key":"6449_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mmcr.2020.06.006","volume":"31","author":"T Ghelfenstein-Ferreira","year":"2021","unstructured":"Ghelfenstein-Ferreira T, Saade A, Alanio A, Bretagne S, Araujo de Castro R, Hamane S, Azoulay E, Bredin S, Delli\u00e8re S (2021) Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU\u2014a case report. Med Mycol Case Rep 31:15\u201318. https:\/\/doi.org\/10.1016\/j.mmcr.2020.06.006","journal-title":"Med Mycol Case Rep"},{"key":"6449_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/jof6020079","volume":"6","author":"EFJ Meijer","year":"2020","unstructured":"Meijer EFJ, Dofferhoff ASM, Hoiting O, Buil JB, Meis JF (2020) Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: a case report. J Fungi (Basel) 6:79. https:\/\/doi.org\/10.3390\/jof6020079","journal-title":"J Fungi (Basel)"},{"key":"6449_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cmi.2020.07.047","volume":"27","author":"M Helleberg","year":"2021","unstructured":"Helleberg M, Steensen M, Arendrup MC (2021) Invasive aspergillosis in patients with severe COVID-19 pneumonia. Clin Microbiol Infect 27:147\u2013148. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.047","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"6449_CR42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","volume":"202","author":"S Van Biesen","year":"2020","unstructured":"Van Biesen S, Kwa D, Bosman RJ, Juffermans NP (2020) Detection of invasive pulmonary aspergillosis in COVID-19 with non-directed bronchoalveolar lavage. Am J Respir Crit Care Med 202:1171\u20131173. https:\/\/doi.org\/10.1164\/rccm.202005-2018LE","journal-title":"Am J Respir Crit Care Med"},{"key":"6449_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcrc.2020.07.002","volume":"59","author":"AW Flikweert","year":"2020","unstructured":"Flikweert AW, Grootenboers MJJH, Yick DCY, du M\u00e9e AWF, van der Meer NJM, Rettig TCD, Kant MKM (2020) Late histopathologic characteristics of critically ill COVID-19 patients: different phenotypes without evidence of invasive aspergillosis, a case series. J Crit Care 59:149\u2013155. https:\/\/doi.org\/10.1016\/j.jcrc.2020.07.002","journal-title":"J Crit Care"},{"key":"6449_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mmcr.2020.06.005","volume":"31","author":"A Mohamed","year":"2021","unstructured":"Mohamed A, Hassan T, Trzos-Grzybowska M, Thomas J, Quinn A, O\u2019Sullivan M, Griffin A, Rogers TR, Talento AF (2021) Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: a lethal combination. Med Mycol Case Rep 31:11\u201314. https:\/\/doi.org\/10.1016\/j.mmcr.2020.06.005","journal-title":"Med Mycol Case Rep"},{"issue":"Suppl 1","key":"6449_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Fl\u00f6rl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Br\u00fcggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, L\u00f6ffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sink\u00f3 J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24(Suppl 1):e1\u2013e38. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/ciw444","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE (2016) Executive summary: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:433\u2013442. https:\/\/doi.org\/10.1093\/cid\/ciw444","journal-title":"Clin Infect Dis"},{"key":"6449_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","volume":"397","author":"JA Maertens","year":"2021","unstructured":"Maertens JA, Rahav G, Lee DG, Ponce-de-Le\u00f3n A, Ram\u00edrez S\u00e1nchez IC, Klimko N, Sonet A, Haider S, Diego V\u00e9lez J, Raad I, Koh LP, Karthaus M, Zhou J, Ben-Ami R, Motyl MR, Han S, Grandhi A, Waskin H, Study investigators (2021) Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet 397:499\u2013509. https:\/\/doi.org\/10.1016\/S0140-6736(21)00219-1","journal-title":"Lancet"},{"key":"6449_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/jac\/dkp026","volume":"63","author":"I Spriet","year":"2009","unstructured":"Spriet I, Annaert P, Meersseman P, Hermans G, Meersseman W, Verbesselt R, Willems L (2009) Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 63:767\u2013770. https:\/\/doi.org\/10.1093\/jac\/dkp026","journal-title":"J Antimicrob Chemother"},{"key":"6449_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/phar.2348","volume":"40","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Seelhammer TG, Barreto EF, Wilson JW (2020) Altered pharmacokinetics and dosing of liposomal amphotericin B and isavuconazole during extracorporeal membrane oxygenation. Pharmacotherapy 40:89\u201395. https:\/\/doi.org\/10.1002\/phar.2348","journal-title":"Pharmacotherapy"},{"key":"6449_CR50","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/jac\/dkab012","volume":"76","author":"R Van Daele","year":"2021","unstructured":"Van Daele R, Br\u00fcggemann RJ, Dreesen E, Depuydt P, Rijnders B, Cotton F, Fage D, Gijsen M, Van Zwam K, Debaveye Y, Wauters J, Spriet I (2021) Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 76:1234\u20131241. https:\/\/doi.org\/10.1093\/jac\/dkab012","journal-title":"J Antimicrob Chemother"},{"key":"6449_CR51","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1128\/AAC.00251-13","volume":"57","author":"M Hoenigl","year":"2013","unstructured":"Hoenigl M, Duettmann W, Raggam RB, Seeber K, Troppan K, Fruhwald S, Prueller F, Wagner J, Valentin T, Zollner-Schwetz I, W\u00f6lfler A, Krause R (2013) Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother 57:3262\u20133267. https:\/\/doi.org\/10.1128\/AAC.00251-13","journal-title":"Antimicrob Agents Chemother"},{"key":"6449_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijantimicag.2016.10.010","volume":"49","author":"A Veringa","year":"2017","unstructured":"Veringa A, Geling S, Span LF, Vermeulen KM, Zijlstra JG, van der Werf TS, Kosterink JG, Alffenaar JC (2017) Bioavailability of voriconazole in hospitalised patients. Int J Antimicrob Agents 49:243\u2013246. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.010","journal-title":"Int J Antimicrob Agents"},{"key":"6449_CR53","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1128\/AAC.02830-15","volume":"60","author":"MA Encalada Ventura","year":"2016","unstructured":"Encalada Ventura MA, van Wanrooy MJ, Span LF, Rodgers MG, van den Heuvel ER, Uges DR, van der Werf TS, Kosterink JG, Alffenaar JW (2016) Longitudinal analysis of the effect of inflammation on voriconazole trough concentrations. Antimicrob Agents Chemother 60:2727\u20132731. https:\/\/doi.org\/10.1128\/AAC.02830-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl_1","key":"6449_CR54","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ofid\/ofw172.1498","volume":"3","author":"A Desai","year":"2016","unstructured":"Desai A, Kovanda L, Andes D, Lademacher C, Townsend R, Engelhardt M, Bonate P (2016) No dose adjustment necessary for isavuconazole in obese patients. Open Forum Infect Dis 3(suppl_1):1950. https:\/\/doi.org\/10.1093\/ofid\/ofw172.1498","journal-title":"Open Forum Infect Dis"},{"key":"6449_CR55","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.01765-10","volume":"55","author":"MP Pai","year":"2011","unstructured":"Pai MP, Lodise TP (2011) Steady-state plasma pharmacokinetics of oral voriconazole in obese adults. Antimicrob Agents Chemother 55:2601\u20132605. https:\/\/doi.org\/10.1128\/AAC.01765-10","journal-title":"Antimicrob Agents Chemother"},{"key":"6449_CR56","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jac\/dkz546","volume":"75","author":"RE Wasmann","year":"2020","unstructured":"Wasmann RE, Smit C, van Donselaar MH, van Dongen EPA, Wiezer RMJ, Verweij PE, Burger DM, Knibbe CAJ, Br\u00fcggemann RJM (2020) Implications for IV posaconazole dosing in the era of obesity. J Antimicrob Chemother 75:1006\u20131013. https:\/\/doi.org\/10.1093\/jac\/dkz546","journal-title":"J Antimicrob Chemother"},{"key":"6449_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00228-017-2213-7","volume":"73","author":"RW Townsend","year":"2017","unstructured":"Townsend RW, Akhtar S, Alcorn H, Berg JK, Kowalski DL, Mujais S, Desai AV (2017) Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics. Eur J Clin Pharmacol 73:669\u2013678. https:\/\/doi.org\/10.1007\/s00228-017-2213-7","journal-title":"Eur J Clin Pharmacol"},{"key":"6449_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13054-015-0753-8","volume":"19","author":"TH Kiser","year":"2015","unstructured":"Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I (2015) Evaluation of sulfobutylether-beta-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care 19:32. https:\/\/doi.org\/10.1186\/s13054-015-0753-8","journal-title":"Crit Care"},{"key":"6449_CR59","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/AAC.00626-12","volume":"56","author":"MJ Dolton","year":"2012","unstructured":"Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ (2012) Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother 56:4793\u20134799. https:\/\/doi.org\/10.1128\/AAC.00626-12","journal-title":"Antimicrob Agents Chemother"},{"key":"6449_CR60","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","volume":"202","author":"R Nyga","year":"2020","unstructured":"Nyga R, Maizel J, Nseir S, Chouaki T, Milic I, Roger PA, Van Grunderbeeck N, Lemyze M, Totet A, Castelain S, Slama M, Dupont H, Sendid B, Zogheib E (2020) Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial. Am J Respir Crit Care Med 202:708\u2013716. https:\/\/doi.org\/10.1164\/rccm.201910-1931OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6449_CR61","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/s41379-020-00661-1","volume":"33","author":"AC Borczuk","year":"2020","unstructured":"Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, Mostyka M, Elsoukkary S, He B, Del Vecchio C, Fortarezza F, Pezzuto F, Navalesi P, Crisanti A, Fowkes ME, Bryce CH, Calabrese F, Beasley MB (2020) COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 33:2156\u20132168. https:\/\/doi.org\/10.1038\/s41379-020-00661-1","journal-title":"Mod Pathol"},{"key":"6449_CR62","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"HP Jia","year":"2005","unstructured":"Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr (2005) ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79:14614\u201314621. https:\/\/doi.org\/10.1128\/JVI.79.23.14614-14621.2005","journal-title":"J Virol"},{"key":"6449_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","volume":"24","author":"J Wang","year":"2020","unstructured":"Wang J, Yang Q, Zhang P, Sheng J, Zhou J, Qu T (2020) Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care 24:299. https:\/\/doi.org\/10.1186\/s13054-020-03046-7","journal-title":"Crit Care"},{"key":"6449_CR64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/thx.54.11.1047","volume":"54","author":"RJ Boots","year":"1999","unstructured":"Boots RJ, Paterson DL, Allworth AM, Faoagali JL (1999) Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 54:1047\u20131049. https:\/\/doi.org\/10.1136\/thx.54.11.1047","journal-title":"Thorax"},{"key":"6449_CR65","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W (2020) Corticosteroids as adjunctive therapy in the treatment of Influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med 48:e98\u2013e106. https:\/\/doi.org\/10.1097\/CCM.0000000000004093","journal-title":"Crit Care Med"},{"key":"6449_CR66","doi-asserted-by":"publisher","first-page":"571156","DOI":"10.3389\/fphar.2020.571156","volume":"11","author":"W Cheng","year":"2020","unstructured":"Cheng W, Li Y, Cui L, Chen Y, Shan S, Xiao D, Chen X, Chen Z, Xu A (2020) Efficacy and safety of corticosteroid treatment in patients with COVID-19: a systematic review and meta-analysis. Front Pharmacol 11:571156. https:\/\/doi.org\/10.3389\/fphar.2020.571156","journal-title":"Front Pharmacol"},{"key":"6449_CR67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395:473\u2013475. https:\/\/doi.org\/10.1016\/S0140-6736(20)30317-2","journal-title":"Lancet"},{"key":"6449_CR68","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A et al (2020) Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA 324:1317\u20131329. https:\/\/doi.org\/10.1001\/jama.2020.17022","journal-title":"JAMA"},{"key":"6449_CR69","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, J\u00fcni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, M\u00f8ller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324:1330\u20131341. https:\/\/doi.org\/10.1001\/jama.2020.17023","journal-title":"JAMA"},{"key":"6449_CR70","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"AC Gordon","year":"2021","unstructured":"REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buzgau A, Cheng AC, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Lamontagne F, Lawler PR, Leavis HL, Linstrum KM, Litton E, Lorenzi E, Marshall JC, Mayr FB, McAuley DF, McGlothlin A, McGuinness SP, McVerry BJ, Montgomery SK, Morpeth SC, Murthy S, Orr K, Parke RL, Parker JC, Patanwala AE, Pettil\u00e4 V, Rademaker E, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Sligl WI, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Webb SA, Derde LPG (2021) Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med 384:1491\u20131502. https:\/\/doi.org\/10.1056\/NEJMoa2100433","journal-title":"N Engl J Med"},{"issue":"397","key":"6449_CR71","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"2021","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021(397):1637\u20131645. https:\/\/doi.org\/10.1016\/S0140-6736(21)00676-0","journal-title":"Lancet"},{"key":"6449_CR72","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942\u2013949. https:\/\/doi.org\/10.1038\/ni1496","journal-title":"Nat Immunol"},{"key":"6449_CR73","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, Thumerelle C, Oksenhendler E, Boutboul D, Thomas C, Hoarau C, Lebranchu Y, Stephan JL, Cazorla C, Aladjidi N, Micheau M, Tron F, Baruchel A, Barlogis V, Palenzuela G, Mathey C, Dominique S, Body G, Munzer M, Fouyssac F, Jaussaud R, Bader-Meunier B, Mahlaoui N, Blanche S, Debr\u00e9 M, Le Bourgeois M, Gandemer V, Lambert N, Grandin V, Ndaga S, Jacques C, Harre C, Forveille M, Alyanakian MA, Durandy A, Bodemer C, Suarez F, Hermine O, Lortholary O, Casanova JL, Fischer A, Picard C (2012) Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) 91:e1\u2013e19. https:\/\/doi.org\/10.1097\/MD.0b013e31825f95b9","journal-title":"Medicine (Baltimore)"},{"key":"6449_CR74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","volume":"15","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latg\u00e9 JP (2017) Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol 15:661\u2013674. https:\/\/doi.org\/10.1038\/nrmicro.2017.90","journal-title":"Nat Rev Microbiol"},{"key":"6449_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00138-7","author":"FL van de Veerdonk","year":"2021","unstructured":"van de Veerdonk FL, Br\u00fcggemann RJM, Vos S, de Hertogh G, Wauters J, Reijers MH, Netea MG, Schouten JA, Verweij PE (2021) COVID-19 associated Aspergillus tracheobronchtitis: the interplay between viral tropism, host defense and fungal invasion. Lancet Resp Med. https:\/\/doi.org\/10.1016\/S2213-2600(21)00138-7","journal-title":"Lancet Resp Med"},{"key":"6449_CR76","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202009-1225RL","author":"CA Gao","year":"2021","unstructured":"Gao CA, Bailey JI, Walter JM, Coleman JM, Malsin ES, Argento AC, Prickett MH, Wunderink RG, Smith SB, NU COVID Investigators (2021) Bronchoscopy on intubated COVID-19 patients is associated with low infectious risk to operators. Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202009-1225RL","journal-title":"Ann Am Thorac Soc"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-021-06449-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T01:04:22Z","timestamp":1627261462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-021-06449-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6449"],"URL":"https:\/\/doi.org\/10.1007\/s00134-021-06449-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PE Verweij reported grants from Gilead Sciences, MSD, Pfizer, Mundipharma, ThermoFisher, and F2G, and non-financial support from OLM and IMMY, outside the submitted work. All contracts were through Radboudumc, and all payments were invoiced by Radboudumc. RJM Br\u00fcggemann served as consultant to Astellas Pharma, Inc., F2G, Amplyx, Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc., and has received unrestricted and research grants from Astellas Pharma, Inc., Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc. All contracts were through Radboudumc, and all payments were invoiced by Radboudumc. E Azoulay has received fees for lectures from Pfizer, Gilead, MSD, Alexion and Baxter. His institution received research support from Fisher&Payckle, Jazz pharma and Gilead. M Bassetti has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, Bayer, BioM\u00e8rieux, Cidara, Correvio, Menarini, MSD, Nabriva, Pfizer, Roche and Shionogi. S Blot received research funding from Pfizer and MSD, travel support from Pfizer, MSD, and Gilead, and invited speaker for Pfizer and Gilead. J.B. Buil T Calandra reported advisory board membership from Astellas, Basilea, Cidara, MSD, Sobi, ThermoFisher, and GE Healthcare and data monitoring board membership from Novartis, all outside the submitted work. Fees are paid to its institution. T Chiller reported no conflicts of interest. CJ Clancy has been awarded investigator-initiated research grants from Astellas, Merck, Melinta, and Cidara for projects unrelated to this project, served on advisory boards or consulted for Astellas, Merck, the Medicines Company, Cidara, Scynexis, Shionogi, Qpex and Needham & Company, and spoken at symposia sponsored by Merck and T2Biosystems. OA Cornely is supported by the German Federal Ministry of Research and Education and the European Commission, and has received research grants from, is an advisor to, or received lecture honoraria from Actelion, Allecra Therapeutics, Amplyx, Astellas, Basilea, Biosys UK Limited, Cidara, Da Volterra, Entasis, F2G, Gilead, Grupo Biotoscana, Janssen Pharmaceuticals, Matinas, Medicines Company, MedPace, Melinta Therapeutics, Menarini Ricerche, Merck\/MSD, Octapharma, Paratek Pharmaceuticals, Pfizer, PSI, Rempex, Scynexis, Seres Therapeutics, Tetraphase, Vical. P Depuydt reported no conflicts of interest. P Koehler is supported by the German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany and has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany, and received lecture honoraria from and\/or is advisor to Akademie f\u00fcr Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., and University Hospital, LMU Munich outside the submitted work. K Lagrou received consultancy fees from MSD, SMB Laboratories Brussels and Gilead Sciences, travel support from Pfizer, grant from Thermo Fisher Scientific and speaker fees from Gilead Sciences, Pfizer, and FUJIFILM WAKO. D de Lange C Lass-Fl\u00f6rl received research funding from Pfizer, Gilead and Egger, travel support from Pfizer, MSD, and Gilead, and has served as invited speaker for MSD, Pfizer, Gilead, Basilea and Angelini. RE Lewis has received research support from Merck, and has served an invited speaker for Gilead, Cidara. O Lortholary has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is a consultant for Gilead, Novartis and F2G. P Wei-Lun Liu has received research grants from MSD, Pfizer, and has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is an advisor to Pfizer, Gilead. J Maertens reported personal fees and non-financial support from Basilea Pharmaceuticals, Bio-Rad Laboratories, Cidara, F2G Ltd, Gilead Sciences, Merck, Astellas, Scynexis, and Pfizer Inc. and grants from Gilead Sciences, IMMY and OLM. MH Nguyen receives research grants from the National Institute of Health, Astellas, Pulmocide, Scynexis,and Mayne, and participates in clinical trials funded by the Mycosis Study Group and F2G. TF Patterson received research grants or clinical trial support to UT Health San Antonio from Cidara and F2G and is an NIH ACTT and ACTIV investigator; is a consultant for Appili, Basilea, F2G Gilead, Mayne, Merck, Pfizer, Scynexis, and Sfunga. B Rijnders was investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag. A Rodr\u00edguez report research grant from Gilead Science and fees for lectures from Pfizer, Gilead, ThermoFisher, Biomerieux and MSD. J Schouten reported grants from MSD and Pfizer, outside the submitted work. All contracts were through Radboudumc, and all payments were invoiced by Radboudumc. J Wauters reports grants, personal fees and other from MSD, Gilead Sciences, Pfizer, outside the submitted work. F van de Veerdonk reports grants from Gilead Sciences, grants from Sobi, outside the submitted work. I Martin-Loeches reported grants from Gilead, MSD and Pfizer, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}